Impact of Etiology on the Outcomes in Heart Failure Patients Treated with Cardiac Resynchronization Therapy: A Meta-Analysis
Figure 3
Pooled Analyses of Secondary Outcomes (the Change from Baseline) in NICM Group versus ICM Group.
WMD in change of Left Ventricular Ejection Fraction (A), SMD in change of Left Ventricular End-systolic Volume (B), WMD in change of 6-Min Walking Distance (C), and WMD in change of Quality of Life (D). WMD, weighted mean difference; SMD, standardized mean difference; and other abbreviations as in Figure 2.